(Q31448541)

2 July 2017

1 reference

title

Montelukast: data from clinical trials in the management of asthma (English)

1 reference

2 July 2017

0 references

K V Blake

1

1 reference

2 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

Annals of Pharmacotherapy

2 July 2017

published in

1 reference

2 July 2017

volume

33

1 reference

2 July 2017

issue

12

1 reference

2 July 2017

page(s)

1299-1314

1 reference

Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study

2 July 2017

cites work

1 reference

Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity.

21 January 2018

1 reference

Bone mineral density and bone metabolism of prepubertal children with asthma after long-term treatment with inhaled corticosteroids.

21 January 2018

1 reference

A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group

21 January 2018

1 reference

Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids

21 January 2018

1 reference

The role of leukotrienes in inflammation

21 January 2018

1 reference

Leukotrienes and airway responses.

21 January 2018

1 reference

Treatment of asthma with drugs modifying the leukotriene pathway.

21 January 2018

1 reference

Clinical activity of leukotriene inhibitors.

21 January 2018

1 reference

Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy

21 January 2018

1 reference

Airway smooth muscle and disease workshop: leukotrienes and related eicosanoids

21 January 2018

1 reference

Antileukotrienes in the treatment of asthma

21 January 2018

1 reference

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

21 January 2018

1 reference

Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist

21 January 2018

1 reference

Characterization of the human cysteinyl leukotriene CysLT1 receptor

21 January 2018

1 reference

Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females.

21 January 2018

1 reference

Single dose pharmacokinetics, safety and tolerability of MK-0476, a new leukotriene D4-receptor antagonist, in healthy volunteers

21 January 2018

1 reference

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.

21 January 2018

1 reference

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma

21 January 2018

1 reference

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

21 January 2018

1 reference

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

21 January 2018

1 reference

Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.

21 January 2018

1 reference

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

21 January 2018

1 reference

Exhaled nitric oxide: a new lung function test

21 January 2018

1 reference

Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast

21 January 2018

1 reference

Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment

21 January 2018

1 reference

Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.

21 January 2018

1 reference

Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma

21 January 2018

1 reference

Use of inhaled corticosteroids and the risk of cataracts.

21 January 2018

1 reference

Association of inhaled corticosteroid use with cataract extraction in elderly patients.

21 January 2018

1 reference

Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients

21 January 2018

1 reference

Osteoporosis in the corticosteroid-treated patient with asthma.

21 January 2018

1 reference

Measuring compliance with inhaled medication in asthma

21 January 2018

1 reference

NO in Exhaled Air of Asthmatic Children Is Reduced by the Leukotriene Receptor Antagonist Montelukast

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.18430

1 reference

2 July 2017

1 reference